Meeting
2016 Gastrointestinal Cancers Symposium
“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.
Authors
Jy Ming Chiang
Chang Gung Memorial Hospital, Tao-Yuan, Taiwan
Jy Ming Chiang , Hsin Yuan Hung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 754)
DOI
10.1200/jco.2016.34.4_suppl.754
Abstract #
754
Poster Bd #
N7
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer (NORTH/HGCSG1003).
First Author: Toshiaki Shichinohe
Poster
2022 ASCO Annual Meeting
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection.
First Author: Yu Pengfei
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.
First Author: Daniel Walden
Poster
2018 ASCO Annual Meeting
Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration.
First Author: Anthony Frank Shields